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Salivary glands are known immune effector sites and considered to be part of the whole
mucosal immune system. The aim of the present study was to assess the salivary immune
response to rotavirus (RV) infection through the analysis of the cytokine immune profile in
saliva.
Material and methods
A prospective comparative study of serial saliva samples from 27 RV-infected patients
(sampled upon admission to the hospital during acute phase and at convalescence–i.e. at
least three months after recovery) and 36 healthy controls was performed. Concentrations
of 11 salivary cytokines (IFN-γ, IFN-α2, IL-1β, IL-6, IL-8, IL-10, IL-15, IL12p70, TNF-α, IFN-
λ1, IL-22) were determined. Cytokine levels were compared between healthy controls acute
infection and convalescence. The correlation between clinical data and salivary cytokine
profile in infected children was assessed.
Results
The salivary cytokine profile changes significantly in response to acute RV infection. In RV-
infected patients, IL-22 levels were increased in the acute phase with respect to convales-
cence (P-value < 0.001). Comparisons between infected and control group showed signifi-
cant differences in salivary IFN-α2, IL-1β, IL-6, IL-8, IL-10 and IL-22. Although acute-phase
levels of IL-12, IL-10, IL-6 and IFN-γ showed nominal association with Vesikari’s severity,
this trend did not reach statistical significance after multiple test adjustment.
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Conclusions
RV infection induces a host salivary immune response, indicating that immune mucosal
response to RV infection is not confined to the intestinal mucosa. Our data point to a whole
mucosal implication in the RV infection as a result of the integrative mucosal immune
response, and suggest the salivary gland as effector site for RV infection.
Introduction
Epithelial cells are more than mere physical barriers to infection; they also have a central role
in immune responses and are key in tissue remodeling after healing [1]. Oral mucosa epithelial
cells, located at the interface between the external and internal environment, are routinely
exposed to large amounts of substances, including pathogens. Several studies have revealed
that the oral epithelium–like all other epithelia-, is highly dynamic and displays a broad spec-
trum of activities related to immunity and host defense [2,3]. The major secretion associated
with the oral mucosa epithelium is saliva, produced by the salivary glands and secreted to the
oral cavity through the oral mucosa. Among the substances produced in saliva are cytokines
[4], soluble regulating agents of immune responses, secreted by epithelial cells in response to
diverse stimuli such as injury, infection or inflammation [5].
Saliva from the sublingual compartment has demonstrated to be an excellent non-invasive
proxy for intestinal immune induction [6,7]. Induction of mucosal immunity in the intestinal
Peyer’s patches, results in an effector response at distant sites such as the oral mucosa, func-
tionally based on the compartmentalized mucosal immune system [7,8]. This fact has long
been demonstrated with IgA and plasma cells [9–12], but, to the best of our knowledge, never
before with the induction of an epithelial cytokine response. Until now, studies had only
shown an oral epithelial cytokine response to local inflammation or infections of the mouth
such as periodontitis [13–15], or in autoimmune diseases affecting oral mucosa such as Sjög-
ren disease [16].
Here, we hypothesized that RV intestinal infection induces in the host a complete cytokine
response at the oral mucosa epithelial cells, which can be measured in the sub-lingual compart-
ment. If true, this would constitute supportive evidence to the suggestion that RV infection
induces a whole mucosal immune response in locations as distant as the oral mucosa.
Methods and material
Patients and controls
A total of 27 RV infected patients admitted to hospital and 36 healthy children scheduled to
receive RV vaccination were enrolled in this study. Written consent from parents was obtained
for all subjects involved in this study. Approval for this project was obtained from the Ethics
Committee for Clinical Research of Galicia before patients and healthy controls were recruited.
RV-infected patients were prospectively recruited at the Hospital Clı́nico Universitario of
Santiago de Compostela (Spain) during the period 2013–2014, all of them hospitalized with
acute gastroenteritis and with a positive RV antigen detected in stool. For the RV-infected
group, demographic and clinical data were obtained, including detailed symptoms scores dur-
ing the course of illness such as temperature, number of vomiting episodes per day and dura-
tion of vomiting, the severity of diarrhea (number of stools per day, duration of diarrhea and
level of dehydration), and length of stay in hospital, as well as Vesikari’s severity score.
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In the same period, 36 healthy children who attended to the infectology consultation for
scheduled rotavirus vaccination were enrolled in the study.
Samples
Saliva samples were collected at recruitment in acute phase and at convalescence (>90 days
after infection) for RV-infected patients, and at recruitment (baseline pre-vaccination) for
control group.
A sample from unstimulated sublingual saliva was obtained with oral swabs (Whatman)
placed under the tongue for 5 min. The swabs were eluted in 0.4 ml of phosphate buffered
saline (PBS), and then centrifuged at 800 g for 10 min to remove mucin and epithelial cells.
Supernatants were stored at -30˚C prior to analysis.
Detection of cytokines in saliva samples
The cytokine detection assay was performed according to the instructions of the Milliplex Map
human cytokine detection kit purchased from Millipore (Merck Millipore, Billerica, MA). The
assay kit consisted of a “9-plex” panel of several cytokines (IFN-α2, IL-8, IL-1β, IL-10, IL-15,
IL12p70, TNF-α, IFN-U and IL-6). Assays were carried out on a Luminex™ 200 platform.
For IFN-λ and IL-22 detection, a DuoSet ELISA kit containing capture/detection antibodies
and recombinant protein standard were purchased from R&D Systems (Minneapolis, MN)
Statistical analysis
Data are reported as median and range interquartile, unless otherwise indicated. Statistical
analysis was performed using R software v. 3.0.2 [17] (with Mann-Whitney for comparison
between patients of different groups); P-value 0.05 was considered as the nominal threshold
for statistical significance. Non-parametric statistics were used for analysis because the data
were not normally distributed.
Cytokine levels in patients from the same group were compared by the Wilcoxon rank-sum
test. Spearman’s rank correlation coefficients were used to quantify the association between
cytokine concentration and clinical parameters. Bonferroni correction was employed to cor-
rect for multiple test.
Results
Characteristics of patients and clinical data
A total of 63 children were enrolled in the study, classified in two groups: RV-infected group
(n = 27) and control group (n = 36). RV-infected group age ranged from 1 to 40 months
(median of 12 months) at recruitment and from 5 to 47 (median of 18 months) at convales-
cence. Clinical characteristics of the patients are summarized in Table 1. Control group age
ranged from 1.8 to 2.3 months (median of 2.1 months) at recruitment.
Salivary cytokine levels were measured in all groups, RV-infected (acute phase), RV-conva-
lescence and control group.
Cytokine profiles in saliva of RV patients
RV-infected patients in the acute phase showed differences in median levels of IL-22 compared
to the convalescence period (Tables 2 and 3 and Fig 1). Levels of IL-22 were found signifi-
cantly increased (P-value < 0.001) in acute-phase samples (47.9 pg/ml) compared with the
convalescence period (12.5 pg/ml). All other differences found were not significant after Bon-
ferroni adjustment. We could not detect signal for IFN-λ in any sample of both groups.
Rotavirus infection oral mucosa response
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Saliva from acute-phase infected patients showed significant differences when compared to
those measured in for healthy controls for the following cytokines: IFN-x2, IL-1β, IL-6, IL-8
and IL-22 (Tables 2 and 3, and Fig 1).
Finally, IL-1β, IL-6, IFN-α2, IL8, and TNF-α were differentially expressed in convalescent
vs. healthy control children (Tables 2 and 3, and Fig 1).
Statistically significant correlations between cytokine levels were observed between acute
and convalescence patients (Fig 2 and S1 Table). As expected, saliva sample from acute-phase
patients showed a correlative rise of pro-inflammatory cytokines (e.g. IFN-γ, IL-1β, IL-6, IL-8
and TNF-α). Convalescence saliva samples showed similar significant correlation and rise of
pro-inflammatory cytokines, especially at IL-6, IL-10 and IL-15 rise. IL-22, a cytokine of non-
epithelial origin did not show correlation with any other cytokines in both groups of samples.
Salivary cytokine profiles and clinical parameters
We first conducted analyses to examine if salivary cytokine levels in acute-phase infected chil-
dren were age dependent, to avoid potential interferences in our analysis. There were no




(n = 27) (n = 27) (n = 36)
Age (months) 12 (1–40) 18 (5–47) 2.1 (1.8–2.3)
Sex (Male:Female) 16:11 16:11 18:18
Vesikari’s score 11.0 (3.4) – –
Length of stay in hospital (days) 5.7 (3.0) – –
Temperature (˚C) 38.7 (0.6) – –
Vomiting episodes per day 3.1 (4.7) – –
Duration of vomiting (days) 2.0 (1.9) – –
Number of stools per day 4.9 (5.0) – –
Duration of diarrhea (days) 4.5 (2.1) – –
Level of dehydration 1.6 (1.1) – –
https://doi.org/10.1371/journal.pone.0195314.t001
Table 2. Salivary concentrations of selected cytokines in RV-infected patients (acute phase and at convalescence) and in healthy control children. Data are shown as
median (pg/ml) and interquartile ranges (25%-75%) for all groups. nd: not detectable.
RV-infected patients Control Group
Cytokines Acute phase Convalescence
IFN-α2 30.1 (12.2–68.5) 71 (31.2–76.8) 216.1 (110.4–337.1)
IFN-γ 4.1 (1.9–6.5) 4.3 (3.9–5.2) 4 (2–7.5)
IL-1β 3.2 (1.8–4.6) 3 (2.3–3.5) 1.4 (0.9–2)
IL-6 1.4 (0.7–2.9) 1.2 (1.1–2.3) 3.6 (2.1–6.8)
IL-8 387 (168.4–1435.3) 248.6 (178.8–249.7) 62.6 (48.7–143.9)
IL-10 3.8 (1–13) 9 (2.1–10.9) 13 (6.6–17.1)
IL-15 2.6 (1.3–5.1) 2.3 (1.6–2.6) 1.7 (0.8–3.1)
IL12p70 7.6 (3.2–15.4) 7.6 (4.3–11.4) 3.2 (2.5–9.4)
TNF-α 2 (1–4.4) 2.9 (1.8–3.3) 0.9 (0.5–1.5)
IL-22 47.9 (6.8–58.8) 12.5 (11.7–13.5) 7.9 (5.2–15.5)
IFN-λ1 nd nd nd
https://doi.org/10.1371/journal.pone.0195314.t002
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significant age-related differences in any cytokine response (Table 4), as determined by Spear-
man’s rank correlation coefficients.
We next examined possible associations between the levels of cytokines in acute-phase
saliva, and several clinical parameters of disease (Table 4). We did not find any cytokine signif-
icantly associated to Vesikari’s total severity score, length of hospital stay, or age.
Discussion
To the best of our knowledge, the results from the present study provide the first evidence for
a cytokine-mediated response in oral mucosa in children exposed to natural RV infection. The
oral epithelial cells recognize pathogen invaders through their specific innate receptors and
stimulate epithelial cells to produce cytokines either by constitutive or inductive pathways
[18]. This epithelial cytokine response in oral mucosa had been demonstrated for local inflam-
matory or infectious events but, it had not been investigated previously for an intestinal infec-
tion such as RV.
Rotavirus, the leading cause of severe gastroenteritis in infants and young children around
the world, infects preferentially terminally differentiated villous enterocytes of the upper small
intestine [19]. Although many case reports show that infection is not limited to the gastrointes-
tinal tract [20] [21] with evidences of systemic transcriptional changes caused by rotavirus
infection [22], so far there was no evidence for RV infection of oral mucosa epithelium.
Significant differences in the levels of several cytokines were observed in infected RV-
patients, suggesting a systemic response to RV also expressed at the oral mucosa. Our data also
show that there is a complex pattern of cytokine co-expression, suggesting that a coordinated
immune response associated to a rise of pro-inflammatory cytokines exists. This is particularly
remarkable in acute-phase saliva samples, suggesting transference of the inflammatory
response from intestine to saliva in a well-orchestrated way.
Acute-phase RV-infected patients showed increased levels of several cytokines, and particu-
larly of IL-22, all of them representative of innate immunity. IL-8 and IL-12, both increased in
our patients, are potent pro-inflammatory cytokines and chemo-attractant factors for diverse
immune cells such as polymorphonuclear cells and lymphocytes. These cytokines are secreted
by the epithelium in response to pathogen entry [23,24]. IFN-γ, a cytokine from the adaptive
system that is produced mainly by T-lymphocytes, was not found to be differently expressed in
Table 3. P-values of comparisons between the different groups analyzed in the present study.
Cytokines AC vs. CV AC vs. HC CV vs. HC
IFN-α2 0.0547 <0.0001 0.0001
IFN-γ 0.3038 0.7845 0.908
IL-1β 0.1429 0.0001 0.0001
IL-6 0.0502 0.0011 0.0007
IL-8 0.0290 <0.0001 <0.0001
IL-10 0.1907 0.0014 0.0053
IL-15 0.2774 0.0479 0.3517
IL12p70 0.4524 0.0374 0.0245
TNF-α 0.1893 0.0053 0.0017
IL-22 0.0002 0.0032 0.0769
IFN-λ1 - - -
AC: acute patients; CV: convalescence patients; HC: healthy control children;
: significant after Bonferroni correction.
https://doi.org/10.1371/journal.pone.0195314.t003
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our subjects. IFN-λ1, a recently described cytokine that seems to play an important role in the
epithelium defense from viral pathogens, was not even detected in our patients. Although
there is no evidence of RV entry into oral mucosa epithelial cells, our data suggest that the oral
mucosa responds by secreting these pro-inflammatory mediators, presumably through
immune communication from intestinal epithelia, showing a global host mucosal immune
response to RV infection.
IFN-α2 levels were found significantly low in acute-phase infected patients when compared
to healthy children. Several studies indicate that the constitutive expression of type I interferon
in mucosal surfaces plays an important role in controlling the proliferation and function of the
epithelium, and regulating epithelial renewal [25–27]. Rotaviruses have evolved a range of spe-
cific mechanisms to evade the type I interferon antiviral response of the host in order to
achieve successful replication in the host epithelium [28], for example preventing detection of
viral components, or inhibiting the function of transcription factors that initiate interferon
response [29]. However, it is unlikely that the low levels of IFN-α observed in oral mucosa of
infected patients are due to specific inhibition promoted by RV, since there is no evidence for
entry of virus in oral epithelia. It seems more likely that intestinal mucosa injury interferes
with the normal homeostasis of interferon production in the whole mucosa.
Fig 1. Salivary cytokine concentrations for all groups. Data are represented as median ± interquartile range. Only P-values surpassing Bonferroni threshold are
indicated.
https://doi.org/10.1371/journal.pone.0195314.g001
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High levels of IL-22, a cytokine not associated with an epithelial origin, were found in oral
mucosa of acute-phase RV-infected patients. This cytokine belongs to the superfamily of IL-10
[30] and is mainly synthetized by innate lymphoid cells (ILC3), dendritic cells and natural
killer (NK) cells [31]. There is no evidence of IL-22 synthesis by epithelial cells; therefore, the
presence of this cytokine in oral mucosa is most likely associated with a lymphoid innate
immune response, suggesting presence of activated lymphoid cells in oral mucosa in response
Fig 2. Heatmap of cytokine expression correlations in RV-infected patients (acute-phase vs convalescence). Heatmap of infected patients: below the
diagonal are the correlations in acute phase samples, while above the diagonal are the correlations in convalescence samples. Blue and red colors
indicate the direction of the correlation as indicated in the legend. Asterisks indicate statistical significant correlations after Bonferroni correction.
https://doi.org/10.1371/journal.pone.0195314.g002
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to intestinal RV infection. A major target for this cytokine are epithelial cells (respiratory and
gut) where it acts as a potent mediator of cellular inflammatory process against invader patho-
gens [32]. Administration of IL-22 and IL-18 in intestinal epithelial cells in mice, produced
elimination of RV infection acting as a broad-spectrum antiviral agent [33]. Also, IL-22 has
been related to protective functions in epithelia through a regenerative action on injured epi-
thelia after infection [32,34,35]. Salivary levels of IL-22 show a significant correlation with clin-
ical parameters of Sjögren’s disease, indicating a critical role for this cytokine in the
pathogenesis of this autoimmune disease that targets salivary glands [36]. The finding of ele-
vated levels of IL-22 in oral mucosa shows that not only epithelial cells respond to the intestinal
RV infection producing pro-inflammatory signals, but also mucosal lymphoid innate cells are
involved in this response.
Several clinical parameters were investigated with regards to cytokine levels, although none
of them reached statistical significance. IFN-γ, IL-6, IL-10 and IL12p70 were statistically corre-
lated with Vesikari’s severity score, but significance did not surpass multiple test correction
(Table 4). Whether this reflects just a lack of association or insufficient statistical power to
detect them can only be addressed through more powerful cohort studies.
Besides limited sample size, age differences between children from RV-infected (acute-
phase and convalescence) and healthy control groups might constitute a limitation to our
study. However, we did not find any link between age and cytokine levels in saliva samples in
either our samples or the literature, even for sera cytokine levels. [37]
In conclusion, our data suggest the existence of an oral mucosa cytokine host response to
RV infection. Several pro-inflammatory innate cytokines produced by epithelial cells, such as
IL-8, IL-1β, IL-12 and TNF-α, were elevated in saliva after infection. In addition, production
of IL-22, presumably from mucosa innate lymphoid circulating cells, was elevated. IFN-α2 was
inhibited probably as consequence of RV homeostasis disruption.
Although the present study needs further validation, our preliminary data indicate that RV
infection is not confined to the intestinal mucosa, suggesting a whole mucosal implication as a
result of the integrative mucosal immune response.
Supporting information
S1 Table. Correlation coefficients between saliva cytokine levels in RV-infected subjects at
baseline and at convalescence. Spearman’s correlations rank coefficient for each pair of
Table 4. Correlation coefficients between saliva cytokine levels in RV-infected patients and age, Vesikari’s severity score and length of hospital stay. P-value of
Spearman’s rank correlation and Pearson’s correlation coefficients for cytokines values are expressed between parentheses.
Age (months) Vesikari’s severity score Length of stay (days)
Cytokines Spearman’scorrelation Pearson’s correlation Spearman’scorrelation Pearson’scorrelation Spearman’scorrelation Pearson’scorrelation
IFN-α2 -0.09 (0.660) -0.09 (0.67) -0.09 (0.648) -0.1 (0.611) -0.16 (0.419) 0.03 (0.881)
IFN-γ -0.3 (0.132) -0.17 (0.396) -0.4 (0.039) -0.23 (0.249) -0.04 (0.83) 0.02 (0.925)
IL-1β 0.16 (0.436) 0.12 (0.543) 0.09 (0.670) -0.01 (0.978) -0.32 (0.109) -0.15 (0.449)
IL-6 -0.28 (0.155) -0.26 (0.184) -0.43 (0.026) -0.25 (0.204) -0.11 (0.582) 0.44 (0.020)
IL-8 0.14 (0.474) 0.18 (0.370) -0.09 (0.665) -0.11 (0.571) -0.1 (0.633) -0.01 (0.948)
IL-10 -0.24 (0.236) 0.02 (0.918) -0.41 (0.035) -0.07 (0.712) -0.08 (0.690) -0.26 (0.199)
IL-15 -0.32 (0.099) -0.28 (0.153) -0.31 (0.121) -0.22 (0.271) -0.09 (0.658) -0.06 (0.758)
IL12p70 -0.44 (0.020) -0.32 (0.101) -0.42 (0.031) -0.35 (0.072) 0.03 (0.867) 0.26 (0.192)
TNF-α 0.02 (0.916) 0.07 (0.735) -0.18 (0.374) -0.03 (0.884) -0.25 (0.205) -0.31 (0.111)
IL-22 0.37 (0.059) 0.27 (0.179) 0.04 (0.837) -0.07 (0.729) -0.26 (0.190) -0.16 (0.417)
IFN-λ1 - - - - - -
https://doi.org/10.1371/journal.pone.0195314.t004
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cytokine values (P-value between parentheses) for RV-infected patients. Correlations for cyto-
kines measured in acute-phase are shown below the diagonal; correlations for cytokines mea-
sured in convalescent- phase are shown above the diagonal.
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